{"nct_id":"NCT04133909","title":"Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2019-10-30","start_date_type":"ACTUAL","primary_completion_date":"2024-08-08","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}